. 2017 Jan 1;7(1):98–114.

Table 2.

Microsatellite markers and ID test results in the 16 cases with discordant germline/tumor mutation status

Case	DNA sample	BRCA1 locus (17q21.31)			BRCA2 locus (13q13.1)

		D17S323^*	D17S1322^*	D17S801^**	D13S260^**	D13S1698^**	D13S267^**
1	Germline	151/157	116/119	228/239
1	Tumor	151/157	116/119	228/239
2	Germline	148/150	113/116	232/232
	Tumor	148/150	113/116	232/232
	Normal	148/150	113/116	232/232
3	Germline	148/151	113/116	232/234
3	Tumor	148/151	113/116	232/234
4	Germline	148/151	119/122	238/240
4	Tumor	148/151	119/122	238/240
5	Germline	148/150	116/116	232/232
5	Tumor	148/150	116/116	232/232
6	Germline	148/150	116/116	232/238
6	Tumor	148/150	116/116	232/238
7	Germline	148/150	113/116	232/232
	Tumor	148/150	113/116	232/232
	Normal	148/150	113/116	232/232
8	Germline	146/146	116/116	230/232
8	Tumor	146/146	116/116	230/232
9	Germline	148/150	116/116	232/232
9	Tumor	148/150	116/116	232/232
10	Germline	148/150	116/116	230/232
10	Tumor	148/150	116/116	230/232
11	Germline	148/150	116/116	232/238
11	Tumor	148/150	116/116	232/238
12	Germline	148/150	116/116	230/232
12	Tumor	148/150	116/116	230/232
13	Germline	Not available
	Germline^#	150/160	116/119	228/236	159/163	153/155	147/154
	Tumor	148/150	116/119	232/236	159/160	151/155	148/154
14	Germline	148/150	113/116	232/242	155/165	155/161	141/141
14	Tumor	148/150	116/116^{^}	232/232^{^}	165/165	150/155	143/143
15^##	Germline	151/157	116/125	228/232	155/167	159/171	149/156
	Tumor	151/153	122/122	240/240	159/160	164/151	148/154
	Tumor (2nd)				159/160	164/151	148/154
16^##	Germline	150/159	116/119	240/240
16^##	Tumor	148/150	116/116	232/232

Intragenic markers;

^**

Extragenic markers;

^{^}

Germline allele lost in tumor (case TN021);

Genomic DNA was unavailable from the proband, so her daughther’s DNA was used instead;

^##

Mismatched cases, excluded from the analysis.